Participation in 24th Annual Biotech in Europe Forum in Basel

Participation in 24th Annual Biotech in Europe Forum in Basel – presenter at Rising Stars: Biotech Seed Companies session on 25 September 2024

Annegret Van der Aa CEO of Cantoni Therapeutics

We are excited to announce the appointment of Annegret Van der Aa as CEO of Cantoni Therapeutics! Annegret’s experience and skills will be highly valuable to bringing our assets to the clinic with the aim of bringing novel treatments for cardiometabolic diseases to the patient.